NCT07775300
ClinicalTrials.gov
- Trial ID
- T-ctgov-NCT07775300
- Registry
- ClinicalTrials.gov
- NCT number
- NCT07775300
- CTIS number
- 2025-522310-24-00
- Sponsor, as registered
- Eli Lilly and Company
- Phase
- PHASE3
- Indication
- Depressive Disorder, Major
- Status
- RECRUITING
- Start date
- 2026-08-14
- Primary completion
- 2028-12
- Registered countries
- Australia, Brazil, Canada, China, Germany, Greece, Japan, Mexico, Poland, Puerto Rico, South Korea, Spain, Taiwan, United Kingdom, United States
- Sites
- 170
The sponsor's registered location list, which states intent rather than approval.
clinicaltrials.govctgov registryverified 2026-10-19
Notes on the record
Supersedes the T-ctgov-NCT07775300 row verified 2026-10-06. Changed: site_count 169 -> 170. Fields read from the ClinicalTrials.gov v2 API record on 2026-10-19 17:29 CEST (last update posted 2026-10-07). site_count is the number of location entries.
Company
Through brenipatide (LY3537031): Lilly
Cited in
Issues quoting NCT07775300 in their own text.